Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.64 USD | -1.36% | -3.19% | -36.47% |
Apr. 05 | Sector Update: Health Care Stocks Lean Higher Pre-Bell Friday | MT |
Apr. 04 | Caribou Gets FDA Clearance For Phase 1 Testing of CB-010 Cell Therapy in Lupus Patients | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.47% | 333M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- CRBU Stock
- News Caribou Biosciences, Inc.
- HC Wainwright Adjusts Caribou Biosciences Price Target to $24 From $23, Maintains Buy Rating